U2AF1 and myelodysplastic syndrome: VAF > 40% of U2AF1 was shown to be an independent factor of short overall survival in MDS patients, but the presence of co-mutated genes (such as ASXL1, RUNX1, TET2) with U2AF1 can affect disease progression and prognosis [63].